Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Hepatitis delta genotype 5 geassocieerd met betere prognose dan genotype 1
mrt 2020 | Hepatitis, Virale infecties